.

Deeper Knowledge, Faster

  • Identify first generic entrants
  • Obtain formulation and manufacturing information
  • Drug patents in 130+ countries

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Novartis
Cantor Fitzgerald
Federal Trade Commission
Fuji
Teva
McKesson
Merck
AstraZeneca
Chinese Patent Office
Dow

Generated: December 12, 2017

DrugPatentWatch Database Preview

Lisinopril - Generic Drug Details

« Back to Dashboard

What are the generic drug sources for lisinopril and what is the scope of lisinopril freedom to operate?

Lisinopril
is the generic ingredient in four branded drugs marketed by Silvergate Pharms, Accord Hlthcare, Apotex Inc, Aurobindo, Hikma Intl Pharms, Invagen Pharms, Ivax Sub Teva Pharms, Lupin, Mylan, Prinston Inc, Sandoz, Sun Pharm Inds Ltd, Teva, Watson Labs, Wockhardt, Merck, and Alvogen Malta, and is included in twenty-one NDAs. There are two patents protecting this compound. Additional information is available in the individual branded drug profile pages.

Lisinopril has one patent family member in one country.

There are twenty-one drug master file entries for lisinopril. Eighty-one suppliers are listed for this compound.

Pharmacology for lisinopril

Medical Subject Heading (MeSH) Categories for lisinopril

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Patent Submitted Product Substance Delist Req. Exclusivity Expiration
MylanLISINOPRILlisinoprilTABLET;ORAL076071-001Jul 1, 2002ABRXNoNo► Subscribe► Subscribe► Subscribe► Subscribe
TevaLISINOPRILlisinoprilTABLET;ORAL075783-004Jul 1, 2002DISCNNoNo► Subscribe► Subscribe► Subscribe► Subscribe
WockhardtLISINOPRILlisinoprilTABLET;ORAL078402-003Apr 19, 2007ABRXNoNo► Subscribe► Subscribe► Subscribe► Subscribe
AurobindoLISINOPRILlisinoprilTABLET;ORAL077622-003Feb 22, 2006ABRXNoNo► Subscribe► Subscribe► Subscribe► Subscribe
LupinLISINOPRILlisinoprilTABLET;ORAL077321-002Sep 9, 2005ABRXNoNo► Subscribe► Subscribe► Subscribe► Subscribe
SandozLISINOPRILlisinoprilTABLET;ORAL075999-003Jul 1, 2002DISCNNoNo► Subscribe► Subscribe► Subscribe► Subscribe
MylanLISINOPRILlisinoprilTABLET;ORAL076071-005Jul 1, 2002ABRXNoNo► Subscribe► Subscribe► Subscribe► Subscribe
Invagen PharmsLISINOPRILlisinoprilTABLET;ORAL203508-002Oct 29, 2013ABRXNoNo► Subscribe► Subscribe► Subscribe► Subscribe
Silvergate PharmsQBRELISlisinoprilSOLUTION;ORAL208401-001Jul 29, 2016RXYesYes► Subscribe► Subscribe► Subscribe► Subscribe
TevaLISINOPRILlisinoprilTABLET;ORAL075783-003Jul 1, 2002DISCNNoNo► Subscribe► Subscribe► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Expired Orange Book Patents for Generic Ingredient: lisinopril

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Alvogen MaltaZESTRILlisinoprilTABLET;ORAL019777-001May 19, 1988► Subscribe► Subscribe
MerckPRINIVILlisinoprilTABLET;ORAL019558-006Jan 28, 1994► Subscribe► Subscribe
Alvogen MaltaZESTRILlisinoprilTABLET;ORAL019777-002May 19, 1988► Subscribe► Subscribe
Alvogen MaltaZESTRILlisinoprilTABLET;ORAL019777-003May 19, 1988► Subscribe► Subscribe
Alvogen MaltaZESTRILlisinoprilTABLET;ORAL019777-005Apr 29, 1993► Subscribe► Subscribe
MerckPRINIVILlisinoprilTABLET;ORAL019558-003Dec 29, 1987► Subscribe► Subscribe
Alvogen MaltaZESTRILlisinoprilTABLET;ORAL019777-006Jan 20, 1999► Subscribe► Subscribe
MerckPRINIVILlisinoprilTABLET;ORAL019558-004Oct 25, 1988► Subscribe► Subscribe
Alvogen MaltaZESTRILlisinoprilTABLET;ORAL019777-004May 19, 1988► Subscribe► Subscribe
MerckPRINIVILlisinoprilTABLET;ORAL019558-002Dec 29, 1987► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

International Patent Family for Ingredient: lisinopril

Country Document Number Estimated Expiration
World Intellectual Property Organization (WIPO)2017075368► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

The estimated expiration dates shown above are derived by simply adding 20 years to the priority date.
Due to the complexity of determining patent expirations even in a single country, compounded by the diversity of global patent laws, it is advisable to have patent counsel verify freedom to operate.

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the plans and pricing

Serving leading biopharmaceutical companies globally:

Johnson and Johnson
Chubb
Argus Health
Citi
Harvard Business School
Cantor Fitzgerald
QuintilesIMS
Accenture
AstraZeneca
US Army

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:

botpot